The negative results of the SELECT study do not necessarily discredit the selenium-cancer prevention hypothesis.

@article{ElBayoumy2009TheNR,
  title={The negative results of the SELECT study do not necessarily discredit the selenium-cancer prevention hypothesis.},
  author={Karam El-Bayoumy},
  journal={Nutrition and cancer},
  year={2009},
  volume={61 3},
  pages={285-6}
}
The lack of treatment options for the worried well prostate cancer patients and the issues of cancer recurrence and hormone resistant disease in cancer survivors remain enormous obstacles (1). However, the long latency of prostate cancer presents an ample opportunity to intervene before the disease can progress to an invasive state. Thus, there is a strong need for mechanismbased naturally occurring or synthetic agents that can inhibit prostate cancer development and/or progression and for… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Selenium cytotoxicity in cancer.

Basic & clinical pharmacology & toxicology • 2014
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Are clinical trials the "gold standard" for cancer prevention research?

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • 2008

Selenium and anticarcinogenesis: underlying mechanisms.

Current opinion in clinical nutrition and metabolic care • 2008

Chemoprevention of prostate cancer through dietary agents: progress and promise.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • 2007

Similar Papers

Loading similar papers…